These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1562119)

  • 1. Mechanistic and clinical aspects of acquired long QT syndromes.
    Lazzara R
    Ann N Y Acad Sci; 1992 Jan; 644():48-56. PubMed ID: 1562119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative antiarrhythmic activity of beta-N-hexamethyleneimino-P-butoxypropiophenone, quinidine and novocaine amide in aconitine auricular fibrillation and flutter in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(4):415-8. PubMed ID: 5357458
    [No Abstract]   [Full Text] [Related]  

  • 3. [Procaine amide quinidine as prophylactic drugs against relapse of atrial fibrillation].
    Aberg H; Cullhed I
    Nord Med; 1968 Jun; 79(24):781-2. PubMed ID: 4880307
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-arrhythmia agents].
    Kaufmann G
    Med Klin; 1974 May; 69(18):778-86. PubMed ID: 4134645
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atrial fibrillation, heart failure and QT interval prolongation -- diastolic and therapeutic difficulties].
    Stec S; Zaborska B; Makowska E
    Kardiol Pol; 2006 Jan; 64(1):87-90; discussion 91-2. PubMed ID: 16444640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of quinidine and novocainamide on auricular flutter and fibrillation and the effectiveness of defibrillatory discharges under experimental conditions].
    Babskii EB; Makarychev VA; Orlov VN
    Kardiologiia; 1973 Mar; 13(3):91-7. PubMed ID: 4717191
    [No Abstract]   [Full Text] [Related]  

  • 7. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the in situ effect of diethylaminoethylamide of dehydroabietic acid (substance E-25), quinidine and procaine on the fibrillation threshold of the heart in anesthetized cats].
    Vrbovský L
    Bratisl Lek Listy; 1969; 52(3):275-85. PubMed ID: 5345611
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
    Forester D
    Chest; 1979 Jun; 75(6):745. PubMed ID: 436537
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct current shock and antidysrhythmic drugs.
    Szekely P; Wynne NA; Pearson DT; Batson GA; Sideris DA
    Br Heart J; 1970 Mar; 32(2):209-18. PubMed ID: 5440516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-cardioversion drug therapy in cases of atrial fibrillation.
    Thakur AK; Shreenivas
    J Indian Med Assoc; 1974 Sep; 63(5):145-50. PubMed ID: 4448913
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs for cardiac arrhythmias associated with myocardial infarction.
    Med Lett Drugs Ther; 1966 Aug; 8(17):66-8. PubMed ID: 5979424
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relative effectiveness of various antiarrhythmia drugs in experimental aconitine arrhythmia].
    Vrbovský L
    Bratisl Lek Listy; 1971; 56(6):669-80. PubMed ID: 5157092
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of atrial fibrillation.
    GRISSOM RL
    Ill Med J; 1956 Feb; 109(2):53-8. PubMed ID: 13294869
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiarrhythimic properties of ethmozine].
    Kaverina NV; Senova ZP; Vikxliàev IuI; Ul'iànova OV
    Farmakol Toksikol; 1970; 33(6):693-7. PubMed ID: 4103389
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolonged quinidine half-life with associated toxicity in a patient with hepatic failure.
    Stanek EJ; Simko RJ; DeNofrio D; Pavri BB
    Pharmacotherapy; 1997; 17(3):622-5. PubMed ID: 9165569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute atrial fibrillation in the emergency room. Which is the best drug for a rapid sinus rhythm conversion?].
    César LA; Serrano CV; Pamplona D; D'Avila AL; Ferreira JF; Amato RV; Pfeferman E; Scanavacca M; Sosa EA; Bellotti G
    Arq Bras Cardiol; 1994 Dec; 63(6):481-4. PubMed ID: 7605232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular fibrillation in Wolff-Parkinson-White syndrome, type A.
    Papa LA; Saia JA; Chung EK
    Heart Lung; 1978; 7(6):1015-9. PubMed ID: 251167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The emergency treatment of acute disorders of heart rhythm following surgical intervention in the thoracic cavity].
    Lebedewa RN
    Acta Anaesthesiol Scand Suppl; 1966; 24():319-24. PubMed ID: 6003612
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antifibrillatory properties of new alkoxynaphthoic acid-esters in comparison with quinidine and procaine amide].
    Igarashi T; Hashimoto N
    Arzneimittelforschung; 1968 Oct; 18(10):1274-8. PubMed ID: 5755706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.